The Endocrine Society has concerns of possible delays in care and other problematic areas of The Lancet Commission’s proposed new obesity framework; a Commission author cites ‘conceptual confusions.’ ...

The Lancet obesity framework aims to improve risk assessment but risks delaying treatment and deepening health inequities, according to recent evaluations.

It is important to recognize various disordered eating behaviors among pediatric patients with obesity, according to speakers ...

Liver disease cases and treatment costs are surging in India, with younger people and smaller cities increasingly affected.

Revised diagnostic framework may limit access to early treatment, widen healthcare dispari ...

Guidance from three obesity associations offers recommendations for specific obesity medications and spells out the need to reduce stigma. Will it help?

This retrospective analysis examines employees with obesity and reports on glucagon-like peptide-1 receptor agonist use, comorbidities, and work outcomes over time. Objectives: Obesity has a US ...

Liver disease is rising in India, yet awareness remains alarmingly low, leading to delayed diagnosis and treatment ...

Fatty liver disease has become one of the most common liver conditions globally, closely tied to rising rates of obesity and metabolic disorders. Often described as a silent disease, it can progress ...

In new research being presented at the European Congress on Obesity in Istanbul, Turkey (12–15 May) and published in The ...